Researchers at IIT Jodhpur develop antimicrobial peptide from snake venom

September 18, 2023 | Monday | News

Peptide molecule has been found to be biocompatible based on in-vitro cytotoxicity studies

Researchers at the Indian Institute of Technology (IIT) Jodhpur have conceptualised, designed, and synthesised an antimicrobial peptide molecule, SP1V3_1, from snake venom, that can kill gram-positive and gram-negative bacteria like E. coli, P. aeruginosa, K. pneumoniae, and MRSA (methicillin-resistant Staphylococcus aureus) by adopting a helical conformation while interacting with bacterial membranes. 

The peptide molecule has been found to be non-toxic based on various studies. The peptide was also found to promote wound healing in the murine model and prevent on-site post-surgical infections by MRSA.

In this design strategy, the primary aim has been to reduce toxicity of the snake venom without loosing its anti-microbial property. Thus, the researchers truncated the snake venom peptide and eliminated the toxic part. Further, they stitched helical short peptide at N-terminus for the smooth entry of the newly designed therapeutic inside the bacterial cell. 

According to the researchers, the peptide can therapeutically be implemented as a component of an ointment (alone or in combination with other drugs/peptides) for wound disinfection and healing, as an injectable/oral drug for systemic administration, or as an aerosolised formulation to treat a wide range of respiratory bacterial pathogens.”

Due to the antimicrobial and immunomodulatory motif, SP1V3_1 can also be tested as an anticancer molecule in the future. 

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy